4YR企业会员
英文名称 | 中文名称 | CAS |
---|---|---|
HA130 | HA 130,自分泌运动抑制剂 | 1229652-21-4 |
IDO5L;INCB14943;INCB024360 analogue | 4-氨基-N-(3-氯-4-氟苯基)-N'-羟基-1,2,5-恶二唑-3-甲脒 | 914471-09-3 |
Pimecrolimus;SDZ-ASM 981;ASM 981 | 吡美莫司 | 137071-32-0 |
Menin-MLL inhibitor MI-2;MI-2;Menin-MLL inhibitor 2;Menin-MLL Inhibitor;MI 2;MI2 | MI-2 (Menin-MLL Inhibitor) | 1271738-62-5 |
MK-8245;MK8245;MK 8245 | MK-8245 | 1030612-90-8 |
IWR-1;IWR-1-endo;endo-IWR 1 | IWR-1 | 1127442-82-3 |
GSK2656157 | GSK2656157 | 1337532-29-2 |
CEP-37440;CEP37440 | CEP-37440 | 1391712-60-9 |
Fruquintinib;HMPL-013 | 呋喹替尼 | 1194506-26-7 |
Elacridar;GW0918;GG918;GF120918;GW120918 | 依克立达 | 143664-11-3 |
GW2580;GW 2580;SC-203877 | GW2580 | 870483-87-7 |
IC-87114;IC87114;IC 87114 | 2-[(6-氨基-9H-嘌呤-9-基)甲基]-5-甲基-3-(2-甲基苯基)-4(3H)-喹唑啉酮 | 371242-69-2 |
TGX-221;TGX221;TGX 221 | (+/-)-7-甲基-2-(吗啉-4-基)-9-(1-苯基氨基乙基)吡啶并[1,2-A]嘧啶-4-酮 | 663619-89-4 |
Alda-1;Alda 1 | N-(1,3-苯并二氧杂环戊烯-5-基甲基)-2,6-二氯苯甲酰胺 | 349438-38-6 |
GTS-21 dihydrochloride;GTS 21 dihydrochloride;DMBX-anabaseine;DMXB-A | (3E)-3-[(2,4-二甲氧基苯基)亚甲基]-3,4,5,6-四氢-2,3'-联吡啶二盐酸盐 | 156223-05-1 |
Timapiprant;OC000459 | [5-氟-2-甲基-3-(喹啉-2-基甲基)吲哚-1-基]乙酸 | 851723-84-7 |
4EGI-1;4EGI1;4EGI 1 | 4EGI-1 | 315706-13-9 |
Taladegib;LY2940680 | 4-氟-N-甲基-N-[1-[4-(1-甲基-1H-吡唑-5-基)-1-酞嗪基]-4-哌啶基]-2-(三氟甲基)苯甲酰胺 | 1258861-20-9 |
PIK-75;PIK75 | 2-甲基-5-硝基-1-苯磺酰[2-[(6-溴咪唑并[1,2-A]吡啶-3-基)亚甲基]-1-甲基肼] | 372196-67-3 |
JNK-IN-8;JNK Inhibitor XVI | JNK-IN-8 | 1410880-22-6 |
ML167;NCGC00188654;CID44968231 | 5-[4-[[(5-甲基-2-呋喃基)甲基]氨基]-6-喹唑啉基]-2-呋喃甲醇 | 1285702-20-6 |
Regadenoson;Lexiscan;CVT-3146 | 瑞加德松 | 313348-27-5 |
TG100-115 | 3,3'-(2,4-二氨基-6,7-蝶啶二基)二苯酚 | 677297-51-7 |
A 438079 hydrochloride;A-438079 hydrochloride;A-438079 HCl;A 438079 (hydrochloride) | A 438079 (hydrochloride) | 899431-18-6 |
GSK0660 | GSK0660 | 1014691-61-2 |
Bentamapimod;AS 602801 | 本塔马莫 | 848344-36-5 |
PF-04217903;PF 04217903;PF04217903 | 2-[4-[1-(喹啉-6-甲基)-1H-[1,2,3]三唑并[4,5-B]吡嗪-6-基]-1H-吡唑-1-基]乙醇 | 956905-27-4 |
Crenolanib;CP-868596;ARO 002 | [1-[2-[5-(3-甲基氧杂环丁烷-3-基甲氧基)苯并咪唑-1-基]喹啉-8-基]哌啶-4-基]胺 | 670220-88-9 |
LB42708 | 2MG | 226929-39-1 |
BMS-265246;BMS265246;BMS 265246 | BMS265246 | 582315-72-8 |
NVP-BVU972 | 6-[[6-(1-甲基-1H-吡唑-4-基)咪唑并[1,2-B]哒嗪-3-基]甲基]喹啉 | 1185763-69-2 |
hPGDS-IN-1 | 化合物HPGDS-IN-1 | 1234708-04-3 |
Acalisib;CAL-120;GS-9820 | GS-9820 | 870281-34-8 |
IWP L6;Porcn?Inhibitor?III;IWP-L6;Porcn Inhibitor III | IWP-L6 | 1427782-89-5 |
JNJ-1661010;JNJ 1661010;Takeda-25;JNJ1661010 | JNJ 1661010 | 681136-29-8 |
KU-55933;ATM Kinase Inhibitor;KU55933 | 2-吗啉-4-基-6-噻蒽-1-基吡喃-4-酮 | 587871-26-9 |
Esomeprazole Magnesium;NEXIUM;(-)-Omeprazole magnesium;(S)-Omeprazole magnesium | 埃索美拉唑镁 | 161973-10-0 |
Esomeprazole Sodium;(S)-Omeprazole sodium | 埃索美拉唑钠 | 161796-78-7 |
Omeprazole sulfide;Omeprazole metabolite Omeprazole sulfide;Ufiprazole | 奥美拉唑硫醚 | 73590-85-9 |
LY310762;LY310762 HCl | LY310762 | 192927-92-7 |
AZ3146;AZ 3146 | AZ3146 | 1124329-14-1 |
Tranilast;MK 341;SB 252218 | 曲尼司特 | 53902-12-8 |
Oritavancin diphosphate;LY333328 diphosphate | 奥利万星二磷酸盐 | 192564-14-0 |
A40926;Dalbavancin Impurity | 达巴霉素杂质 | 102961-72-8 |
AG1024;Tyrphostin AG 1024;AGS 200;Tyrphostin | AG1024 | 65678-07-1 |
KN-62;KN 62;KN62 | 1-[N,O-二(5-异喹啉磺酰基)-N-甲基-L-型酪氨酸]-4-苯基哌嗪 | 127191-97-3 |
Dolasetron Mesylate hydrate;Dalasetron Mesylate Hydrate | 甲磺酸多拉司琼 | 878143-33-0 |
Vismodegib;Erivedge;RG 3616;GDC-0449 | 维莫德吉 | 879085-55-9 |
Veliparib;ABT-888;NSC 737664 | 维利帕尼 | 912444-00-9 |
Ropinirole hydrochloride;SKF 101468 hydrochloride;Ropinirole HCl;SKF-101468A | 盐酸罗匹尼罗 | 91374-20-8 |
Eflornithine hydrochloride hydrate;Difluoromethylornithine hydrochloride hydrate;RMI-71782 hydrochloride hydrate;DFMO hydrochloride hydrate;Eflornithine hydrochloride Monohydrate;Eflornithine hydrochloride;α-difluoromethylornithine hydrochloride hydrate;MDL-71782 hydrochloride hydrate | 依氟鸟氨酸盐酸盐一水合物 | 96020-91-6 |
Dextromilnacipran;Levomilnacipran | 左旋体米那普仑 | 96847-55-1 |
Lumacaftor;VX-809;VRT 826809 | 鲁玛卡托 | 936727-05-8 |
Norgestrel;SH-850;WY-3707;SH-70850;FH 122-A | 炔诺孕酮 | 6533-00-2 |
Thymopentin;TP5 | 胸腺五肽 | 69558-55-0 |
Pirenperone | 哌南氟酮 | 75444-65-4 |
AG490;Tyrphostin AG 490;Zinc02557947;AG-490;Tyrphostin B42;AG 490 | 酪氨酸磷酸化抑制剂AG 490 | 133550-30-8 |
Vidofludimus;4sc-101;SC12267 | 维多氟拉迪莫 | 717824-30-1 |
Barasertib-HQPA;Barasertib;AZD1152-HQPA;1H-Pyrazole-3-acetamide;AZD2811;AZD1152-HQPA|AZD2811 | 5-[[7-[3-[乙基(2-羟基乙基)氨基]丙氧基]-4-喹唑啉]氨基]-N-(3-氟苯基)-1H-吡唑-3-乙酰胺 | 722544-51-6 |
Spebrutinib;AVL-292;LMK-435;CC-292 | AVL292 | 1202757-89-8 |
1-Ethyl-2-benzimidazolinone;1-EBIO | 氯唑沙宗类似物 | 10045-45-1 |
Fostamatinib Disodium;R788 Disodium;R788(Disodium);Tamatinib Fosdium;R788 (Fostamatinib) Disodium | R788(FOSTAMATINIB DISODIUM) | 1025687-58-4 |
MSDC 0160;MSDC0160;CAY10415;Mitoglitazone;MSDC-0160 | MSDC-0160 | 146062-49-9 |
CHIR-98014;CHIR98014;CHIR 98014;CT98014 | CHIR98014(CT98014) | 252935-94-7 |
Masitinib;AB1010 | 马赛替尼(Masitinib) | 790299-79-5 |
BMS-599626;AC480;BMS 599626 | AC480 (BMS-599626) | 714971-09-2 |
CCT 137690;CCT137690 | 甲磺酸阿贝西尼 | 1095382-05-0 |
CEP-28122;CEP 28122;CEP28122 | 5MG | 1022958-60-6 |
Almorexant;ACT 078573 | 阿莫伦特 | 871224-64-5 |
GSK2606414 | GSK2606414 | 1337531-36-8 |
Flavopiridol hydrochloride;HL 275;Alvocidib Hydrochloride;FLAVOPIRIDOL HCL;NSC 649890 HCl;MDL 107826A;NSC 649890 | (-)-2-(2-氯苯基)-5,7-二羟基-8-[(3S,4R)-3-羟基-1-甲基-4-哌啶基]-4H-1-苯并吡喃-4-酮盐酸盐 | 131740-09-5 |
PIK-93;PIK 93;PIK93 | N-[5-[4-氯-3-[[(2-羟基乙基)氨基]磺酰基]苯基]-4-甲基-2-噻唑基]乙酰胺 | 593960-11-3 |
SNS-314 Mesylate;SNS-314 | N-(3-氯苯基)-N'-[5-[2-(噻吩并3,2-D]嘧啶-4-基氨基)乙基]-2-噻唑基]脲甲磺酸盐 (1:1) | 1146618-41-8 |
LGK974;LGK 974;WNT974;LGK-974;NVP-LGK974 | 2',3-二甲基-N-[5-(2-吡嗪基)-2-吡啶基]-[2,4'-联吡啶]-5-乙酰胺 | 1243244-14-5 |
CH5132799 | CH5132799 | 1007207-67-1 |
G-749;G749;G 749 | G-749 | 1457983-28-6 |
Rostafuroxin;PST 2238 | ROSTAFUROXIN | 156722-18-8 |
GSK 650394;GSK650394 | 2-环戊基-4-(5-苯基-1H-吡咯并[2,3-B]吡啶-3-基)苯甲酸 | 890842-28-1 |
PD98059;PD 98059 | 2-(2-氨基-3-甲氧基苯基)-4H-1-苯并吡喃-4-酮 | 167869-21-8 |
OSI-930;OSI 930 | 3-[(4-喹啉甲基)氨基]-N-[4-(三氟甲氧基)苯基]-2-噻吩甲酰胺 | 728033-96-3 |
MK-0752;MK0752 | 顺式-4-[(4-氯苯基)磺酰基]-4-(2,5-二氟苯基)环己烷丙酸 | 471905-41-6 |
SBC-115076;SBC115076;SBC 115076 | sbc-115076 | 489415-96-5 |
Nolatrexed dihydrochloride;Thymitaq;AG 337 | 盐酸诺拉曲塞 | 152946-68-4 |
RI-2;RI 2;RI2 | 化合物RI-2 | 1417162-36-7 |
UNC2881 | UNC2881 | 1493764-08-1 |
Poziotinib;HM781-36B;NOV120101 | 波齐替尼 | 1092364-38-9 |
WAY-100635 Maleate | WAY100635 | 1092679-51-0 |
A-1210477;A 1210477;A1210477 | A-1210477 | 1668553-26-1 |
GSK429286A;RHO-15 | N-(6-氟-1H-吲唑-5-基)-2-甲基-6-氧代-4-[4-(三氟甲基)苯基]-1,4,5,6-四氢-3-吡啶甲酰胺 | 864082-47-3 |
Ro3280;RO 3280;Ro5203280 | RO3280 | 1062243-51-9 |
Org 27569 | ORG275695-氯-3-乙基-N-[2-[4-(1-哌啶基)苯基]乙基-1H-吲哚-2-甲酰胺 | 868273-06-7 |
Decernotinib;VRT-831509;VX-509 | 迪西替尼 | 944842-54-0 |
ADH-1;Exherin | N-钙粘蛋白拮抗剂 | 229971-81-7 |
Gandotinib;LY2784544 | LY 2784544 | 1229236-86-5 |
LY2811376 | (4S)-4-[2,4-二氟-5-(5-嘧啶基)苯基]-5,6-二氢-4-甲基-4H-1,3-噻嗪-2-胺 | 1194044-20-6 |
Rebastinib;DCC-2036;DCC2036;DCC 2036 | N-[3-叔丁基-1-(喹啉-6-基)-1H-吡唑-5-基]-N'-[2-氟-4-[(2-(甲基氨基甲酰基)吡啶-4-基)氧]苯基]脲 | 1020172-07-9 |
KRCA-0008;KRCA 0008;KRCA0008 | 1,1'-((((5-氯嘧啶-2,4-二基)双(氮烷二基))双(3-甲氧基-4,1-亚苯基))双(哌嗪-4,1-二基))双(乙-1-酮) | 1472795-20-2 |
PD173074 | PD173074 | 219580-11-7 |
(E)-Daporinad;APO866;(E)-N-[4-(1-BENZOYL-PIPERIDIN-4-YL)-BUTYL]-3-PYRIDIN-3-YL-ACRYLAMIDE;Daporinad;FK866 | (2E)-N-[4-(1-苯甲酰基-4-哌啶基)丁基]-3-(3-吡啶基)-2-丙烯酰胺 | 658084-64-1 |
联系方式
电话:781-+1-781-999-5354
邮箱:marketing@targetmol.com
网址: https://www.targetmol.com/
产品总数: 19892
地址:36 Washington Street, Wellesley Hills, MA 02481
CB指数:58
国籍:美国